Equities analysts predict that Molina Healthcare, Inc. (NYSE:MOH – Get Rating) will post $4.55 earnings per share for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Molina Healthcare’s earnings, with the highest EPS estimate coming in at $5.02 and the lowest estimate coming in at $4.12. Molina Healthcare posted earnings per share of $3.40 in the same quarter last year, which suggests a positive year over year growth rate of 33.8%. The company is scheduled to issue its next quarterly earnings report on Monday, January 1st.
On average, analysts expect that Molina Healthcare will report full-year earnings of $17.30 per share for the current fiscal year, with EPS estimates ranging from $17.10 to $17.94. For the next year, analysts expect that the company will post earnings of $19.57 per share, with EPS estimates ranging from $19.03 to $20.74. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover Molina Healthcare.
Molina Healthcare (NYSE:MOH – Get Rating) last posted its quarterly earnings results on Wednesday, April 27th. The company reported $4.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.74 by $0.16. Molina Healthcare had a net margin of 2.37% and a return on equity of 31.85%. During the same period last year, the business earned $4.44 earnings per share.
A number of equities analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Molina Healthcare from $308.00 to $311.00 in a research report on Monday, May 2nd. Morgan Stanley dropped their price target on shares of Molina Healthcare from $397.00 to $365.00 and set an “overweight” rating on the stock in a research report on Tuesday, February 22nd. Mizuho lifted their price target on shares of Molina Healthcare from $330.00 to $345.00 and gave the company a “buy” rating in a research report on Friday, February 11th. BMO Capital Markets lifted their price target on shares of Molina Healthcare from $365.00 to $380.00 and gave the company an “outperform” rating in a research report on Monday, February 14th. Finally, Cowen increased their price target on shares of Molina Healthcare from $356.00 to $366.00 in a report on Monday, May 2nd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Molina Healthcare currently has an average rating of “Buy” and a consensus target price of $330.95.
In other Molina Healthcare news, Director Ronna Romney sold 200 shares of the company’s stock in a transaction dated Friday, May 6th. The shares were sold at an average price of $307.94, for a total transaction of $61,588.00. Following the sale, the director now directly owns 16,657 shares of the company’s stock, valued at $5,129,356.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jeff D. Barlow sold 5,000 shares of the company’s stock in a transaction dated Friday, March 4th. The stock was sold at an average price of $315.00, for a total transaction of $1,575,000.00. The disclosure for this sale can be found here. In the last three months, insiders sold 6,186 shares of company stock worth $1,944,337. 1.49% of the stock is currently owned by insiders.
A number of institutional investors have recently modified their holdings of MOH. Covestor Ltd bought a new stake in shares of Molina Healthcare during the fourth quarter valued at approximately $25,000. Steward Partners Investment Advisory LLC grew its stake in shares of Molina Healthcare by 123.5% during the first quarter. Steward Partners Investment Advisory LLC now owns 76 shares of the company’s stock valued at $25,000 after purchasing an additional 42 shares during the last quarter. Prospera Financial Services Inc bought a new stake in shares of Molina Healthcare during the first quarter valued at approximately $26,000. JFS Wealth Advisors LLC grew its stake in shares of Molina Healthcare by 447.1% during the first quarter. JFS Wealth Advisors LLC now owns 93 shares of the company’s stock valued at $31,000 after purchasing an additional 76 shares during the last quarter. Finally, Dark Forest Capital Management LP bought a new stake in shares of Molina Healthcare during the third quarter valued at approximately $39,000. 94.82% of the stock is currently owned by hedge funds and other institutional investors.
MOH traded up $0.21 during midday trading on Friday, hitting $309.53. 392,018 shares of the company’s stock traded hands, compared to its average volume of 424,507. The company has a market cap of $18.17 billion, a PE ratio of 26.34, a price-to-earnings-growth ratio of 1.10 and a beta of 0.80. The stock’s fifty day simple moving average is $324.80 and its 200-day simple moving average is $310.04. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.44 and a quick ratio of 1.44. Molina Healthcare has a one year low of $239.20 and a one year high of $350.19.
Molina Healthcare Company Profile (Get Rating)
Molina Healthcare, Inc provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states.
Get a free copy of the Zacks research report on Molina Healthcare (MOH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Molina Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Molina Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.